Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
VIEWORKS
Ampronix

Dilon Acquires Navigator Gamma Probe Company

By Medimaging International staff writers
Posted on 13 Jan 2014
Dilon Technologies, Inc. (Newport News, VA, USA) has acquired the assets of the Navigator gamma probe business from RMD Instruments Corp. (Watertown, MA, USA), a subsidiary of Dynasil Corporation of America.

RMD Instruments manufactures and sells a range of intraoperative surgical probes that are distributed both in the United States and worldwide. The acquired products are used in surgery for procedures such as pulmonary wedge resection and sentinel lymph node biopsy. The company recently introduced its Navigator 2.0 wireless probe, which has been very well received by the market place.

“In addition to our market leadership in the small field-of-view molecular breast imaging market, this acquisition is consistent with our objective of expanding our product offering in both the diagnostic and surgical segments of the market and comes on the heels of our recent agreement with Digirad [Suwanee, GA, USA],” commented Robert G. Moussa, Dilon’s CEO.

“We are pleased to have found a wonderful home for our Navigator Probe technology, one of the most widely used gamma probes for cancer surgery in the marketplace. Dilon Technologies is well situated to expand the gamma probe market and we look forward to working with them over the coming months to transition the product from our manufacturing facility to Dilon,” commented Peter Sulick, Dynasil’s chairman and interim CEO.

Dynasil, for the time being, will continue to manufacture and distribute the products, maintaining continuity in supply and regulatory compliance.

Dilon Technologies’ keystone product, the Dilon molecular imaging system (MBI), is a high-resolution, small field-of-view digital gamma camera, optimized for MBI/breast-specific gamma imaging (BSGI). MBI utilizes radiotracer uptake to detect the increased metabolic activity of breast lesions and therefore, is not affected by breast density. Both the Dilon 6800 and Acella systems provide high photon sensitivity; and Dilon’s GammaLoc system is the only localization device on the market to enable molecular-guided breast biopsy.

Digirad is one of the largest US providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers, and also sells medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications.

Related Links:

Dilon Technologies
RMD Instruments
Digirad



Channels

Radiography

view channel
Image: Siemens MAMMOMAT FFDM System (Photo courtesy of Siemens Healthcare).

New FFDM Systems Transform Mammography Services Across Northern Ireland

The Northern Ireland Breast Screening Program has been equipped with 14 new mobile and static Full Field Digital Mammography (FFDM) systems. The new systems will replace existing analog ones and enable... Read more

Ultrasound

view channel

Study Suggests Ultrasound Could Eliminate Breast Biopsies in Adolescent Girls

Results of a study published in the Journal of Ultrasound in Medicine in April 2015, indicate that ultrasound examinations could replace invasive excisional tissue biopsies for adolescent girls with breast lumps. The study was carried out by researchers at the Loyola University Health System (Maywood, IL, USA) and included... Read more

Nuclear medicine

view channel
Image: CTE Progression (Photo courtesy of David Geffen School of Medicine at UCLA).

New Innovative Imaging Technique Used for Diagnosing CTE in Athletes

Results of a study published in the April 6, 2015, online edition of the Proceedings of the National Academy of Sciences of the Unites States of America (PNAS) has shown that a Positron Emission Tomography... Read more

General/Advanced Imaging

view channel
Image: Measuring the Magnetic Activity in the Brain of a Child, Using a MEG machine. (Photo courtesy of Children\'s Hospital of Philadelphia).

Study Suggests Language Delay Linked to Chromosome Deletion in Children with Neurological Disorders

A study found that children with neuro-developmental problems born with DNA duplications or deletions on part of chromosome 16, show measurable delays in their ability to process sound and language.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.